Jenburkt Pharmaceuticals informs about compliances-certificate

08 Jul 2022 Evaluate
Jenburkt Pharmaceuticals has informed that it enclosed Certificate pursuant to regulation 74(5) of SEBI (D&P) Regulations, 2018 for the quarter ended on 30.06.2022.

The above information is a part of company’s filings submitted to BSE.

Jenburkt Pharma Share Price

1025.50 -35.80 (-3.37%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×